Continuing SKY-0515 treatment for Huntington's disease
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This is a follow-up study for people with Huntington's disease who already completed an earlier SKY-0515 trial and tolerated it well. Researchers want to see how safe and effective the drug continues to be with longer-term use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have completed a prior SKY-0515 treatment study and followed the protocol well
- You must be able to have blood drawn regularly
- You must be able to attend all scheduled clinic visits and follow all study procedures
- Women of childbearing age must have a negative pregnancy test at the start and use two forms of birth control during the study and for 30 days after stopping the drug
- Men must use birth control during the study and for 90 days after the last dose
- You must not have other conditions that would make it unsafe or impossible to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SKY-0515 in people with Huntington's disease. The goal is to see if it can safely improve symptoms or slow the disease down.
This first-in-human study tests whether SRP-1005, a new drug, is safe and tolerable in people with early Huntington's disease. The drug is designed to reduce levels of a harmful protein in the brain that causes Huntington's symptoms.
This trial tests a gene therapy called SPK-10001 for people with early-stage Huntington's disease. It aims to slow the progression of symptoms by targeting the genetic cause of the disease.
This is an early-phase study testing a new drug (RG6496) for people with Huntington's disease. The study will check the drug's safety and how the body processes it, and it requires two doses given about 6 months apart.
This study gathers small samples of spinal fluid from people affected by Huntington’s disease. Researchers use these samples to better understand the disease and support future treatments. If you join, you’ll need to follow their sample and visit schedule.
This trial tests whether human neural stem cells are safe and tolerable for people with Huntington's disease. It involves a neurosurgical procedure to inject the cells into the brain, along with MRI scans and other monitoring.
Hear when a new Huntington's Disease (HD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.